全球医用纺织品市场规模、份额、趋势和成长分析报告（2026-2034年）

预计生物医学纺织品市场将从 2025 年的 105.2 亿美元成长到 2034 年的 185.6 亿美元，2026 年至 2034 年的复合年增长率为 6.51%。

全球生物医用纺织品市场正稳步成长，其成长主要得益于医疗和医疗设备领域应用范围的不断扩大。这些纺织品广泛应用于创伤护理、外科缝合、植入、绷带和组织工程等领域。外科手术数量的增加、人口老化以及对先进伤口管理解决方案日益增长的需求，都是推动市场成长的关键因素。

材料科学和纺织工程的进步催生了抗菌、可生物降解和高强度纺织材料的研发。具备监测功能的智慧纺织品等创新技术正吸引着现代医疗保健系统的注意。研发投入的增加以及先进材料获得监管部门的核准，正在增强市场机会。

未来几年，对永续且生物相容性纤维解决方案的需求预计将会成长。发展中地区医疗基础设施的扩建以及微创手术技术的广泛应用将进一步推动其普及。凭藉持续的技术创新和融合，生物医用纤维市场拥有巨大的长期成长潜力。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球医用纺织品市场：依纺织品类型划分

• 市场分析、洞察与预测
• 不可生物降解纤维
• 可生物降解纤维
• 其他的

第五章 全球医用纺织品市场：依织物类型划分

• 市场分析、洞察与预测
• 不织布
• 织物
• 其他的

第六章 全球医用纺织品市场：依应用领域划分

• 市场分析、洞察与预测
• 非植入式
• 手术缝合线
• 其他的

第七章 全球医用纺织品市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 门诊部
• 诊所
• 社区医疗保健
• 其他的

第八章 全球医用纺织品市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 亚太其他地区
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Freudenberg SE
  • ATEX Technologies Inc
  • Elkem ASA
  • BioSpace
  • Ahlstrom-MunksjA¶
  • Meister & Cie AG
  • DSM
  • Medtronic
  • Integra LifeSciences Corporation
  • Bally Ribbon Mills
  • Confluent Medical Technologies
  • KCWW
  • MA¶Lnlycke Health Care AB
  • Rochal Industries LLC
  • AstraZeneca

The Biomedical Textiles Market size is expected to reach USD 18.56 Billion in 2034 from USD 10.52 Billion (2025) growing at a CAGR of 6.51% during 2026-2034.

The global biomedical textiles market is growing steadily due to increasing applications in healthcare and medical devices. These textiles are widely used in wound care, surgical sutures, implants, bandages, and tissue engineering. Rising surgical procedures, an aging population, and growing demand for advanced wound management solutions are major factors supporting market growth.

Advancements in material science and textile engineering have led to the development of antimicrobial, biodegradable, and high-strength fabrics. Innovations such as smart textiles with monitoring capabilities are gaining traction in modern healthcare systems. Increased investment in research and development, coupled with regulatory approvals for advanced materials, is strengthening market opportunities.

In the coming years, demand for sustainable and bio-compatible textile solutions is expected to rise. Expanding healthcare infrastructure in developing regions and the growing use of minimally invasive surgical techniques will further drive adoption. With ongoing innovation and technological integration, the biomedical textiles market holds promising long-term growth potential.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Fiber Type

• Non-Biodegradable Fiber
• Biodegradable Fiber
• Others

By Fabric Type

• Non-Woven Fabric
• Woven Fabric
• Others

By Application

• Non-Implantable
• Surgical Sutures
• Others

By End Users

• Hospitals
• Ambulatory Centers
• Clinics
• Community Healthcare
• Others

COMPANIES PROFILED

• Freudenberg SE, ATEX Technologies Inc, Elkem ASA, BioSpace, AhlstromMunksj, Meister Cie AG, DSM, Medtronic, Integra LifeSciences Corporation, Bally Ribbon Mills, Confluent Medical Technologies, KCWW, Mlnlycke Health Care AB, Rochal Industries LLC, AstraZeneca
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOMEDICAL TEXTILES MARKET: BY FIBER TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Fiber Type
• 4.2. Non-Biodegradable Fiber Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Biodegradable Fiber Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOMEDICAL TEXTILES MARKET: BY FABRIC TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Fabric Type
• 5.2. Non-Woven Fabric Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Woven Fabric Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOMEDICAL TEXTILES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Non-Implantable Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Surgical Sutures Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOMEDICAL TEXTILES MARKET: BY END USERS 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Users
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Community Healthcare Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BIOMEDICAL TEXTILES MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Fiber Type
  • 8.2.2 By Fabric Type
  • 8.2.3 By Application
  • 8.2.4 By End Users
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Fiber Type
  • 8.3.2 By Fabric Type
  • 8.3.3 By Application
  • 8.3.4 By End Users
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Fiber Type
  • 8.4.2 By Fabric Type
  • 8.4.3 By Application
  • 8.4.4 By End Users
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Fiber Type
  • 8.5.2 By Fabric Type
  • 8.5.3 By Application
  • 8.5.4 By End Users
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Fiber Type
  • 8.6.2 By Fabric Type
  • 8.6.3 By Application
  • 8.6.4 By End Users
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BIOMEDICAL TEXTILES INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Freudenberg SE
  • 10.2.2 ATEX Technologies Inc
  • 10.2.3 Elkem ASA
  • 10.2.4 BioSpace
  • 10.2.5 Ahlstrom-MunksjA¶
  • 10.2.6 Meister & Cie AG
  • 10.2.7 DSM
  • 10.2.8 Medtronic
  • 10.2.9 Integra LifeSciences Corporation
  • 10.2.10 Bally Ribbon Mills
  • 10.2.11 Confluent Medical Technologies
  • 10.2.12 KCWW
  • 10.2.13 MA¶Lnlycke Health Care AB
  • 10.2.14 Rochal Industries LLC
  • 10.2.15 AstraZeneca